Pluribus Labs’s Baker Hughes BKR Stock Holding History

Pluribus Labs’s Portfolio BKR Stock Details BKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-16,753	Closed	-$403K	–	75
2021 Q4	$403K	Buy	+16,753	New	+$414K	0.43%	77

Other funds holding BKR

General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Pluribus Labs's BKR Position: Q1 2022 in Review

Pluribus Labs sold out of Baker Hughes (BKR) in Q1 2022, closing a stake of 16,753 shares — an estimated $403K sold.

Pluribus Labs first reported a position in BKR in Q4 2021 and held it in 1 quarter. The position peaked at $403K in Q4 2021. 672 funds tracked by Wall St. Rank hold BKR as of Q1 2022.

Pluribus Labs reported no remaining Baker Hughes position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 16,753 Baker Hughes shares in Q1 2022, an estimated $403K.
Pluribus Labs first reported a position in Baker Hughes in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Baker Hughes position peaked at $403K in Q4 2021.
672 funds tracked by Wall St. Rank held Baker Hughes as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.